NeurologyLive® Year in Review 2022: Top Stories in Multiple Sclerosis
NeurologyLive | Multiple Sclerosis
by
1y ago
As part of NeurologyLive®'s Year in Review, take a look at our most-read news in multiple sclerosis in 2022 ..read more
Visit website
This Week on NeurologyLive® — January 2, 2023
NeurologyLive | Multiple Sclerosis
by
1y ago
Here's some of what is coming soon to NeurologyLive® this week ..read more
Visit website
Sexual Dysfunction in MS Alleviated Through Antidepressant Bupropion
NeurologyLive | Multiple Sclerosis
by
1y ago
Over a 12-week trial, females with MS on bupropion demonstrated improvements in sexual satisfaction, sexual desire, vaginal moisture, and orgasm intensity ..read more
Visit website
FDA Action Update, December 2022: Approvals, Submissions, and Requests
NeurologyLive | Multiple Sclerosis
by
1y ago
Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team ..read more
Visit website
Visual Field Defect Higher in Patients with NMOSD-ON Than Idiopathic ON
NeurologyLive | Multiple Sclerosis
by
1y ago
Results from a prospective study demonstrated a higher visual field defect in patients with neuromyelitis optica spectrum disorder-optic neuritis compared with those who had idiopathic optic neuritis ..read more
Visit website
Case Report Highlights Diagnosis of Antibody-Positive NMOSD After Second COVID-19 Vaccination
NeurologyLive | Multiple Sclerosis
by
1y ago
A rare case report illustrated an 80-year-old man with aquaporin-4 antibody-positive NMOSD following a second dose of the Pfizer-BioNTech COVID-19 mRNA BNT162b2 vaccine ..read more
Visit website
NeurologyLive® Friday 5 — January 6, 2023
NeurologyLive | Multiple Sclerosis
by
1y ago
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 6, 2023 ..read more
Visit website
ARISE Results Highlight Dimethyl Fumarate’s Impact as Disease-Modifying Therapy for RIS
NeurologyLive | Multiple Sclerosis
by
1y ago
For the first time ever, investigators identified a treatment benefit that extends the time to clinical conversion in RIS and reduces new or newly-enlarging T-weighted hyperintense lesions ..read more
Visit website
Rare Seronegative NMOSD Case Identified
NeurologyLive | Multiple Sclerosis
by
1y ago
A study reported a rare case of seronegative NMOSD with a middle-aged man in Nepal who did not improve in clinical status and performance after given treatment ..read more
Visit website
This Week on NeurologyLive® — January 9, 2023
NeurologyLive | Multiple Sclerosis
by
1y ago
Here's some of what is coming soon to NeurologyLive® this week ..read more
Visit website

Follow NeurologyLive | Multiple Sclerosis on FeedSpot

Continue with Google
Continue with Apple
OR